The bone marker plot: an innovative method to assess bone turnover in women

被引:27
作者
Bieglmayer, C. [1 ,2 ]
Kudlacek, S. [3 ]
机构
[1] Med Univ Hosp, Dept Med, Gen Hosp, Vienna, Austria
[2] Med Univ Hosp, Chem Lab Diagnost, Gen Hosp, Vienna, Austria
[3] Krankenhaus Barmherzigen Bruder, Dept Med, Vienna, Austria
关键词
Bone turnover; marker; graphic report; POSTMENOPAUSAL OSTEOPOROTIC WOMEN; HIP FRACTURE RISK; BIOCHEMICAL MARKERS; ELDERLY-WOMEN; I COLLAGEN; MINERAL DENSITY; N-TELOPEPTIDE; JPOS COHORT; SERUM; THERAPY;
D O I
10.1111/j.1365-2362.2009.02087.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Biochemical markers of bone turnover reflect the resorptive and reconstructive effects that act on the skeleton. Although elevated markers are commonly interpreted as a sign of an increased turnover rate, the balance between bone resorption and formation is mostly neglected. We introduce a graphic report combining both complementary processes. Materials and methods Bone turnover markers were measured in 599 women (aged 25-74 years). To set up reference ranges, 269 from 599 women were selected because of having T-scores > -1 and inconspicuous basic laboratory data. Concentrations of resorption and formation markers were mathematically transformed to build up plots with four fields, symbolizing fast and slow resorption and fast and slow formation processes. The reference data of bone turnover were represented by a 95% confidence ellipse. For individual marker plots, we converted data of bone turnover markers from therapy follow-up profiles of patients in a similar manner. Results In pre- ,peri- and postmenopausal women (n = 190, 39 +/- 6 years; n = 35, 51 +/- 6 years; n = 44, 55 +/- 5 years, respectively), the medians of the bone resorption marker CrossLaps and of the bone formation markers osteocalcin and aminoterminal propeptide of type I procollagen were 0.13/0.16/0.22 ng mL(-1), 21/21/25 ng mL(-1) and 36/35/45 ng mL(-1), respectively. In postmenopausal women, the marker plots revealed a shift towards accelerated bone resorption. A discrimination from osteopenic women (n = 138) failed. Conclusion The proposed marker plot facilitates the intuitive perception of bone turnover in individual patients as well as in patient groups by a synopsis of the balance between bone formation and resorption with the rate of these processes.
引用
收藏
页码:230 / 238
页数:9
相关论文
共 38 条
[1]
Biochemical markers of bone turnover and prediction of hip bone loss in older women: The study of osteoporotic fractures [J].
Bauer, DC ;
Sklarin, PM ;
Stone, KL ;
Black, DM ;
Nevitt, MC ;
Ensrud, KE ;
Arnaud, CD ;
Genant, HK ;
Garnero, P ;
Delmas, PD ;
Lawaetz, H ;
Cummings, SR .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (08) :1404-1410
[2]
Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women [J].
Bruyere, O ;
Collette, J ;
Delmas, P ;
Rouillon, A ;
Roux, C ;
Seidel, L ;
Richy, F ;
Reginster, JY .
MATURITAS, 2003, 44 (04) :259-265
[3]
Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women:: The EPIDOS study [J].
Chapurlat, RD ;
Garnero, P ;
Bréart, G ;
Meunier, PJ ;
Delmas, PD .
BONE, 2000, 27 (02) :283-286
[4]
Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis [J].
Chen, PQ ;
Satterwhite, JH ;
Licata, AA ;
Lewiecki, EM ;
Sipos, AA ;
Misurski, DM ;
Wagman, RB .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (06) :962-970
[5]
Hormone replacement therapy in postmenopausal women: Urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density [J].
Chesnut, CH ;
Bell, NH ;
Clark, GS ;
Drinkwater, BL ;
English, SC ;
Johnston, CC ;
Notelovitz, M ;
Rosen, C ;
Cain, DF ;
Flessland, KA ;
Mallinak, NJS .
AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01) :29-37
[6]
Biochemical markers of bone metabolism: An overview [J].
Christenson, RH .
CLINICAL BIOCHEMISTRY, 1997, 30 (08) :573-593
[7]
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy [J].
Christgau, S ;
Bitsch-Jensen, O ;
Bjarnason, NH ;
Henriksen, EG ;
Qvist, P ;
Alexandersen, P ;
Henriksen, DB .
BONE, 2000, 26 (05) :505-511
[8]
Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate [J].
Chritiansen, C ;
Tankó, LB ;
Warming, L ;
Moelgaard, A ;
Christgau, S ;
Qvist, P ;
Baumann, M ;
Wieczorek, L ;
Hoyle, N .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (07) :609-613
[9]
ESTIMATING A WOMANS RISK OF HAVING A PREGNANCY ASSOCIATED WITH DOWNS-SYNDROME USING HER AGE AND SERUM ALPHA-FETOPROTEIN LEVEL [J].
CUCKLE, HS ;
WALD, NJ ;
THOMPSON, SG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (05) :387-402
[10]
Delmas PD, 2000, OSTEOPOROSIS INT, V11, pS2, DOI 10.1007/s001980070002